Drreddys Laboratories | RDY - Loan Capital


Drreddys Laboratories reported INR129.19M in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
ANI Pharmaceuticals USD 286M 5.84M Mar/2026
Aurora Cannabis CAD 33.2M 1.79M Dec/2025
Bayer EUR 30.68B 1.15B Mar/2026
Canopy Growth CAD 224.99M 1.34M Dec/2025
Cipla INR 3.82B 840.2M Mar/2026
Drreddys Laboratories INR 129.19M 1.84M Dec/2025
GlaxoSmithKline GBP 14.01B 696M Mar/2026
Hikma Pharmaceutical USD 1.49B 692M Dec/2025
Lonza CHF 3.88B 323M Dec/2025
Novartis USD 37.45B 7.86B Mar/2026
Pacira USD 367.66M 4.53M Mar/2026
Phibro Animal Health USD 597.68M 5.92M Mar/2026
Prestige Brands USD 1.01B 40.28M Mar/2026
Richter Gedeon HUF 15.14B 537M Dec/2025
Sun Pharmaceuticals INR 3.62B 36.4M Sep/2025
Supernus Pharmaceuticals USD 400.38M 21.13M Mar/2022
Teva Pharmaceutical Industries USD 14.02B 971M Mar/2026